Bronchiolitis and SARS-CoV-2.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 05 11 2020
revised: 01 02 2021
accepted: 25 02 2021
pubmed: 13 3 2021
medline: 28 9 2021
entrez: 12 3 2021
Statut: ppublish

Résumé

It has been speculated that the SARS-CoV-2 was already widespread in western countries before February 2020. We gauged this hypothesis by analysing the nasal swab of infants with either bronchiolitis or a non-infectious disease admitted to the Ospedale Maggiore, Milan (one of the first epicentres of SARS-CoV-2 outbreak in Europe) from November 2019. The SARS-CoV-2 RNA was never detected in 218 infants with bronchiolitis (95 females, median age 4.9 months) and 49 infants (22 females, median age 5.6 months) with a non-infectious disease between November 2019 and February 2020. On the contrary, two infants hospitalised for bronchiolitis between March and April 2020 tested positive for SARS-CoV-2. This study does not support the hypothesis that SARS-CoV-2 was already circulating among infants before the official outbreak of SARS-CoV-2 infection. However, it shows for the first time that SARS-CoV-2 might cause bronchiolitis requiring hospitalisation.

Sections du résumé

BACKGROUND BACKGROUND
It has been speculated that the SARS-CoV-2 was already widespread in western countries before February 2020.
METHODS METHODS
We gauged this hypothesis by analysing the nasal swab of infants with either bronchiolitis or a non-infectious disease admitted to the Ospedale Maggiore, Milan (one of the first epicentres of SARS-CoV-2 outbreak in Europe) from November 2019.
RESULTS RESULTS
The SARS-CoV-2 RNA was never detected in 218 infants with bronchiolitis (95 females, median age 4.9 months) and 49 infants (22 females, median age 5.6 months) with a non-infectious disease between November 2019 and February 2020. On the contrary, two infants hospitalised for bronchiolitis between March and April 2020 tested positive for SARS-CoV-2.
CONCLUSIONS CONCLUSIONS
This study does not support the hypothesis that SARS-CoV-2 was already circulating among infants before the official outbreak of SARS-CoV-2 infection. However, it shows for the first time that SARS-CoV-2 might cause bronchiolitis requiring hospitalisation.

Identifiants

pubmed: 33707224
pii: archdischild-2020-321108
doi: 10.1136/archdischild-2020-321108
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

999-1001

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Gregorio Paolo Milani (GP)

Pediatric Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milano, Lombardia, Italy.
Department of Clinical Science and Community Health, Università degli Studi di Milano, Milan, Lombardia, Italy.

Valentina Bollati (V)

Department of Clinical Science and Community Health, Università degli Studi di Milano, Milan, Lombardia, Italy.

Luca Ruggiero (L)

Pediatric Highly Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Lombardia, Italy.

Samantha Bosis (S)

Pediatric Highly Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Lombardia, Italy.

Raffaella Maria Pinzani (RM)

Pediatric Highly Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Lombardia, Italy.

Giovanna Lunghi (G)

Microbiology and Virology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Lombardia, Italy.

Federica Rota (F)

Department of Clinical Science and Community Health, Università degli Studi di Milano, Milan, Lombardia, Italy.

Laura Dioni (L)

Department of Clinical Science and Community Health, Università degli Studi di Milano, Milan, Lombardia, Italy.

Anna Luganini (A)

Università degli Studi di Torino, Torino, Piemonte, Italy.

Carlo Agostoni (C)

Pediatric Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milano, Lombardia, Italy carlo.agostoni@unimi.it.
Department of Clinical Science and Community Health, Università degli Studi di Milano, Milan, Lombardia, Italy.

Paola Marchisio (P)

Pediatric Highly Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Lombardia, Italy.
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milano, Lombardia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH